Co-Chief Scientific Officer
Co-Chief Scientific Officer at REGENERON PHARMACEUTICALS, INC., filing insider transactions on 2026-10-14.
| SEC ↗ |
| 2026-10-14 | REGN | Sale | 127 | $769.30 | $98K | SEC ↗ |
| 2026-10-14 | REGN | Sale | 14 | $759.96 | $11K | SEC ↗ |
| 2026-10-14 | REGN | Sale | 16 | $757.68 | $12K | SEC ↗ |
| 2026-10-14 | REGN | Sale | 192 | $767.39 | $147K | SEC ↗ |
| 2026-10-14 | REGN | Sale | 211 | $772.56 | $163K | SEC ↗ |
| 2026-10-14 | REGN | Sale | 219 | $764.40 | $167K | SEC ↗ |
| 2026-10-14 | REGN | Sale | 224 | $773.40 | $173K | SEC ↗ |
| 2026-10-14 | REGN | Sale | 24 | $758.16 | $18K | SEC ↗ |
| 2026-10-14 | REGN | Sale | 25 | $763.76 | $19K | SEC ↗ |
| 2026-10-14 | REGN | Sale | 27 | $761.36 | $21K | SEC ↗ |
| 2026-10-14 | REGN | Sale | 271 | $765.39 | $207K | SEC ↗ |
| 2026-10-14 | REGN | Sale | 279 | $766.47 | $214K | SEC ↗ |
| 2026-10-14 | REGN | Sale | 283 | $771.56 | $218K | SEC ↗ |
| 2026-10-14 | REGN | Sale | 35 | $755.91 | $26K | SEC ↗ |
| 2026-10-14 | REGN | Sale | 376 | $775.46 | $292K | SEC ↗ |
| 2026-10-14 | REGN | Sale | 38 | $777.76 | $30K | SEC ↗ |
| 2026-10-14 | REGN | Sale | 380 | $779.59 | $296K | SEC ↗ |
| 2026-10-14 | REGN | Sale | 454 | $778.64 | $354K | SEC ↗ |
| 2026-10-14 | REGN | Sale | 463 | $780.63 | $361K | SEC ↗ |
| 2026-10-14 | REGN | Sale | 50 | $781.47 | $39K | SEC ↗ |
| 2026-10-14 | REGN | Sale | 55 | $762.57 | $42K | SEC ↗ |
| 2026-10-14 | REGN | Sale | 6 | $753.76 | $5K | SEC ↗ |
| 2026-10-14 | REGN | Sale | 66 | $776.31 | $51K | SEC ↗ |
| 2026-10-14 | REGN | Sale | 74 | $760.65 | $56K | SEC ↗ |